← All updates
Observational study

Oncology ·

URiM Representation Among Cancer-Care Trainees Rose After 2020

A repeated cross-sectional study of 658,891 US physician trainee observations from 2011 to 2025 found that the share identifying as underrepresented in medicine (URiM) increased after 2020. Increases varied by specialty, and medical oncology showed no statistically significant change over the study period.

This repeated cross-sectional study analyzed Accreditation Council for Graduate Medical Education race and ethnicity data for trainees in medical, radiation, and surgical oncology, general surgery, and primary care from 2011 to 2025. The cohort included 658,891 trainee observations; 113,937 (17.3%) were URiM, defined as American Indian or Alaska Native, Black or African American, Hispanic, Latino or of Spanish origin, or Native Hawaiian or Pacific Islander. The investigators used segmented logistic regression to assess changes before and after 2020.

URiM representation was relatively stable from 2011 (16.1%) to 2020 (16.4%), then rose to 20.4% in 2025. After 2020, the overall odds of a trainee being URiM increased by 5% (OR, 1.05; 95% CI, 1.03-1.08), with a 5% annual increase (OR, 1.05; 95% CI, 1.05-1.06). Significant increases were reported in surgical oncology and general surgery; the largest post-2020 increase was in radiation oncology (OR, 1.20; 95% CI, 1.11-1.30). Medical oncology had no statistically significant change.

The authors noted that URiM representation remained below the diversity of the US population in 2025. The observational workforce analysis describes trends but does not establish whether specific initiatives caused the changes.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

JAMA Oncology: Trends in Racial and Ethnic Representation in the Oncology Trainee Workforce ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.